The Prediction of Mortality in Bleeding Peptic Ulcers Treated with Therapeutic Endoscopy - Lesson Learnt from 3000 Patients

Philip W. Chiu,Enders K. Ng,Francis K. Chan,Wai Keung Leung,Wifred L. Mui,Justin C. Wu,Frances K. Cheung,Wt Siu,Yt Lee,My Yung,James Y. Lau,Joseph J. Sung

DOI: https://doi.org/10.1016/j.gie.2006.03.330

IF: 10.396

2006-01-01

Gastrointestinal Endoscopy

Abstract:Background: Bleeding peptic ulcers is among the leading cause of hospitalization. The reported mortality approaches 10%. We reviewed our prospective database to identify risk factors for in-hospital mortality in patients with bleeding peptic ulcers. Patients & Method: We prospectively collected data on patients with bleeding peptic ulcers since 1993. The parameters collected included the patient's demographics, the characteristics of the peptic ulcer, treatment received and the outcome. We used a univariate followed by multivariate analyses to identify factors for in-hospital deaths. Results: From 1993 to 2003, 9032 patients presented to our endoscopy center with bleeding peptic ulcers. The overall mortality is 4.6%, and the overall rate of rebleeding is 4.9%. 3220 patients had bleeding peptic ulcers with endoscopic stigmata of active bleeding, visible vessel or adherent clot. 229 of them died during hospitalization (7.1%). From multivariate analysis, age > 70, the presence of comorbidities, hematemesis upon presentation, initial systolic BP < 100 mm Hg, in-hospital ulcer bleeding, non-H pylori related ulcer, rebleeding and need of surgery were significant predictors for mortality. (Table 1) Conclusions: For high risk bleeding peptic ulcers, elderly, presence of comorbidities, hematemesis, shock, in-hospital bleeding and ulcer rebleeding are significant predictors for mortality. HP related ulcers are associated with a lower mortality. Table 1comparison of clinical and endoscopic parameters between survivors & non-survivors Variables Survivor (n = 2991) Non-survivor (n = 229) Univariate analysis p value Univariate analysis OR (95% CI) Mult-variate analysis p value Mult-variate analysis OR (95% CI) Age > 70 1213 134 <0.01† 2.07 (1.57-2.71) 0.01 1.47 (1.09-1.98) Male 2046 (68.4%) 157 (68.6%) 0.962 Co-morbidities 1628 (54.4%) 202 (88.2%) <0.001† 6.26 (4.17-9.42) <0.001 4.12 (2.65-6.39) Ischemic heart disease 358 (11.9%) 49 (21.4%) <0.001† 2.00 (1.43-2.80) NSAID user 1029 (34.4%) 78 (34.1%) 0.916 0.99 (0.74-1.31) Aspirin user 309 (10.3%) 27 (11.8%) 0.486 1.16 (0.76-1.76) H pylori positive 1187 (39.7%) 20 (8.7%) <0.001† 0.15 (0.09-0.23) <0.001 0.20 (0.13-0.33) Past history of peptic ulcer 1145 (38.3%) 47 (20.5%) <0.001† 0.42 (0.30-0.58) Hematemesis 435 (14.5%) 55 (24.0%) <0.001† 1.86 (1.35-2.56) 0.039 1.45 (1.02-2.05) SBP < 100 mm Hg 554 (18.5%) 90 (39.3%) <0.001† 2.85 (2.15-3.77) <0.001 2.24 (1.65-3.05) Hb < 8 g/dl 949 (31.7%) 100 (43.7%) <0.001† 1.67 (1.27-2.19) Size of ulcer > 2 cm 553 (18.5%) 56 (24.5%) 0.026† 1.43 (1.04-1.96) In-hospital bleeder 327 (10.9%) 90 (39.3%) <0.001† 5.28 (3.95-7.04) <0.001 2.46 (1.78-3.39) Gastric ulcer 1192 (39.9%) 108 (47.2%) 0.030† 1.35 (1.03-1.76) Posterio-inferior DU 90 (3.0%) 5 (2.2%) 0.477 0.72 (0.29-1.79) Lesser curve GU 46 (1.5%) 5 (2.2%) 0.451 1.43 (0.56-3.63) Active spurter on primary OGD 224 (7.5%) 19 (8.3%) 0.656 1.12 (0.69-1.82) Rebleeding 237 (7.9%) 47 (20.5%) <0.001† 3.00 (2.12-4.25) 0.016 1.63 (1.09-2.41) Surgery 118 (3.9%) 42 (18.3%) <0.001† 5.47 (3.73-8.01) <0.001 4.60 (2.95-7.19) Open table in a new tab